High acceptance rate of COVID-19 vaccination in liver transplant recipients
- 27 May 2021
- journal article
- letter
- Published by Elsevier in Journal of Hepatology
- Vol. 75 (2) , 483-484
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipientsJournal of Hepatology, 2021
- Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipientsJournal of Hepatology, 2021
- Italian association for the study of the liver position statement on SARS-CoV2 vaccinationDigestive and Liver Disease, 2021
- S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Register Nr. 021-031 – Stand: 07.01.21Zeitschrift für Gastroenterologie, 2021
- EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipientsJournal of Hepatology, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- A global survey of potential acceptance of a COVID-19 vaccineNature Medicine, 2020
- Determining risk factors for mortality in liver transplant patients with COVID-19The Lancet Gastroenterology & Hepatology, 2020